Skip to main content
Schedule
  • 10:00-10:05 Course Introduction and WelcomeMahmoud Hosni
  • 10:05-10:40 Basic Ultrasound of the infertile femaleMona Aboulghar
  • 10:40-11:15 Ultrasound assessment of endometrial receptivityNicholas Raine-Fenning
  • 11:15-11:50 Sonohysterography for assessment of uterine cavityMona Aboulghar
  • 11:50-12:20 Coffee Break
  • 12:20-12:55 Ultrasound assessment of ovarian reserveNicholas Raine-Fenning
  • 12:55-13:50 Assessment of early Normal and abnormal PregnancyAhmed El Sheikhah
  • 13:30-14.05 3D ultrasound in infertilityNicholas Raine-Fenning
  • 14:05-14.50 Lunch Break
  • 14:50-15:25 Ultrasound assessment of adenexa Mona Aboulghar
  • 15:25-16:00 First trimester scanning and early detection of anomalies. Ahmed El Sheikhah
  • 16.00-16.30 Interesting Case presentations and discussion
      • 10:15-10:45 The importance of hCG/LH driven activity in ART...Why and when?Enrico Papaleo
      • 10:15-10:45 Where can hCG make a difference?Peter Platteau
      • 08:30-08:50 Predicting factors for successful pregnancy (ovulation induction, IUI, and IVF/ICSI).Alejandro Manzur Yanine
      • 08:50-09:10 Stimulation protocol strategies and the addition of hCG to rFSH in poor responder(s).Dimitris Loutradis
      • 09:10-09:30 Facts and fiction in ART: an evidence- based approach.Mohammed AboulGhar
      • 09:30-10:15 The Morcellation Debate: The Benefits Risks and Prevention of Complications of MorcellationKeith Isaacson
      • 14:00-14:30 The outcome of pregnancy after ART (IVF and ICSIHassan N. Sallam
      • 13:00-13:20 Can we improve endometrial receptivity? An overview of uterine factors that influence implantation.Nicholas Raine-Fenning
      • 13:20-13:40 Luteal phase support in ART cycles: New perspectives?Janos Urbancsek
      • 13:40-14:00 Recurrent implantation failure: What can we do to improve outcome?Antonis Makrigiannakis
      • 15:00-15:30 Improving sucess of ARTKlaus Buhler
      • 15:30-16:00 Tailoring is key to success: Individualized Controlled Ovarian Stimulation Hamed Youssef
      • 16:00-16:15 Discussion
      • 16:30-16:45 Significance of progesterone level in GnRH agonist vs antagonist cycles.Nayla Bushager
      • 16:45-17:00 Progesterone levels and pregnancy outcome in the long GnRH agonist protocol cycles.Wadha Mohawash
      • 17:00-17:15 Serum progesterone on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio as a new prediction model for IVF/ICSI outcome.A Mahran
      • 10:15-10:45 The importance of hCG/LH driven activity in ART...Why and when?Enrico Papaleo
      • 10:45-11:15 Where can hCG make a difference?Peter Platteau
      • 14:00-14:30 The outcome of pregnancy after ART (IVF and ICSIHassan N. Sallam
      • 9:30-10:15 The Morcellation Debate: The Benefits Risks and Prevention of Complications of MorcellationKeith Isaacson
      • 08:30-08:50 Progestogensand postmenopausal hormone replacement therapy: Focuson cardiovascular implications.John C Stevenson
      • 08:50-09:10 Low dose hormone therapy and stroke: How serious is this risk? Raja Sayegh (USA)Raja Sayegh
      • 09:10-09:30 Does hormone replacement therapy cause breast cancer in the menopause?John C Stevenson
      • 13:00-13:20 Osteoporosis - individualized approach to management.Lubna Pal
      • 13:20-13:40 Fracture risk reduction with low dose hormone therapy: Can it be assumed? Raja Sayegh
      • 13:40-14:00 Skeletal health - when menopause is unnatural.Lubna Pal
      • 15:00-15:20 Dr. Samir Abbas Reward Lecture Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technologyMohamed Youssef
      • 15:20-15:40 Adenomyosis and Endometriosis: Is there a correlationAntonis Makrigiannakis
      • 15:40-16:00 Controversies in the management of repeated miscarriage.Abou Bakr El Nashar
      • 16:30-16:45 Post coital test: is it worth to do it in 2015. Long-term pregnancy after a positive and negative post-coital test.Imad Abou Jaoudeh
      • 16:45-17:00 G-CSF treatment increases T-REG peripheral blood levelsin women with recurrent miscarriages.Fabio Scarpellini
      • 17:00-17:15 Mild ovarian stimulation in women with poor ovarian reserve undergoing IVF: a multi-center randomized non-inferiority trial.Mohamed Youssef
      • 17:15-17:30 Accuracy of various transvaginal sonography findings in the diagnosis of genital endometriosis: Original research.Maryam Niknejadi
      • 10:15-11:15 The importance of hCG/LH driven activity in ART...Why and when?Enrico Papaleo
      • Where can hCG make a difference?Peter Platteau
      • 09:30-10:15 The Morcellation Debate: The Benefits Risks and Prevention of Complications of MorcellationKeith Isaacson
      • 14:00-14:30 The outcome of pregnancy after ART (IVF and ICSIHassan N. Sallam
      • 08:30-08:50 Laparoscopic Myomectomy: Your pearls of successKarim Nawfal
      • 08:50-09:10 Palmers point for laparoscopic entry revisited Fady Moiety
      • 09:10-09:30 Advanced laparoscopic surgery and obesity: Adapting techniques to growing epidemicKarim Nawfal
      • 13:00-13:20 Adding Office Hysteroscopy to your Practice.Keith Isaacson
      • 13:20-13:40 The Secret tips and tricks of hysteroscopy.Osama Shawky
      • 13:40-14:00 Energy options for hysteroscopic myomectomy.Keith Isaacson
      • 15:00-15:20 Laparoscopic Hysterectomy: Karim Nawfal
      • 15:20-15:40 Surgical resection of endometrioma prior to IVF: WHERE IS THE EVIDENCE?Omar Sefrioui
      • 15:40-16:00 Combined Laparoscopic ovarian tissue cryopreservation and retrieval of immature oocytes followed by in vitro maturation and vitrification: Results from Oxford Ovarian Tissue Cryopreservation (OTCP) Program.Muhammad Fatum
      • 16:30-16:45 Post thawing Delayed embryo transfer improves the outcome.Osama Shawky
      • 16:45-17:00 Modified procedure for gender selection by intra- uterine insemination for infertile couples.
      • 17:00-17:15 Intrauterine insemination of seminal plasma at time of ovum pickup: Relationship with successful outcome.Mahmoud Hosni
      • 17:15-17:30 Evaluation of the role of the hystrosalpingography in prediction of endometriosis in infertile females.Timer Said
      • 08:30-09:00 IVF data reporting: Outcomes Measurement serving Practice ImprovementJohnny Awwad
      • 09:00-09:30 Three important questions every menopausal woman should ask (with your help!)Raja Sayegh
      • 09:30-09:50 High versus low dose gonadotrophinsin ovarian stimulation.Ioannis E. Messinis
      • 09:50-10:10 Letrozole and uterine receptivityEman A. Elgindy
      • 10:10-10:30 Is there still a place for IUI? Limits and expectations.Alejandro Manzur Yanine
      • 11:00-11:20 Uterine transplantation: New optional treatment for uterine factor infertility Marwan Al Halabi
      • 11:20-11:40 Mitochondrial infusion for oocyte rejuvenation: Fact or Fad?Fadi Choucair
      • 11:40-12:00 GnRH agonist trigger of final oocyte maturation: Challenges ahead.Sarah Faour
      • 12:15-12:30 Advances in Preimplantation Genetic Diagnosis and Screening: A comparison of available technologies. Tamer Hussein
      • 12:30-12:45 GALECTIN-3 blood levels in endometriosis patients are increased: Direct correlation with number of T-REG cells infiltrating endometriosis.Fabio Scarpellini
      • 14:00-14:15 Clinical Applications of quantitative PCR in Pre-implantation Genetic Screening and Diagnosis.Tamer Hussein
      • 14:15-14:30 Evaluation the effect of granulocyte colony stimulating factor versus bromocriptine agonists versus increased dose of human chorionic gonadotrophins in the treatment of luteinized unruptured follicles. Haitham Bahaa
      • 14:30-14:45 To assess the diagnostic value of 3-Dimensional Saline Infusion sonography as a baseline fertility investigation and compare it with hysteroscopy in women undergoing fertility treatment. Ghazala Basir
      • 14:45-15:00 Alteration of HOX clusters (A, B, C and D) expression in ectopic versus eutopic endometrium provides new insights into endometriosis. Masoumeh Golestan Jahromi
      • 09:30-09:50 Circadian Clock Function in reproduction. New Discoveries and future promise.Dimitris Loutradis
      • 09:50-10:10 Obesity and reproductive disorders.
      • 10:10-10:30 Ovarian Ablative Therapy for PCOS: Impact of Obesity on reproductive outcomes.Ahmed Nasr
      • 11:00-11:20 An optimal approach to ovulation induction in PCOS.Ioannis E. Messinis
      • 11:20-11:40 PCOS: Does the Challenge End at Conception?Fadi Mirza
      • 11:40-12:00 Ethnic aspects of epidemiology and pathogenesis of PCOS.Larisa Suturina
      • 12:15-12:30 Contemporary Use of Progestogens in Threatened and Recurrent Miscarriage.Fadi Mirza
      • 12:30-12:45 Assessing long term economic benefits comparing singletons vs twin pregnancyHesham Al-Inany
      • 14:00-14:15 Metformin versus combined oral contraceptives in treatment of adolescent PCOS.Abou Bakr El Nashar
      • 14:15-14:30 A comparative study between GnRH antagonist and long agonist protocols in patients with polycystic ovarian syndrome (PCOS) undergoing In vitro fertilization.A Abdelmeged
      • 14:30-14:45 Prevalence and risk factors of NAFLD in women with PCOS.Maha Al Khaduri
      • 14:45-15:00 Ultrasound endometrial pattern at the time of embryo transfer in IVF and oocyte donation program.Imad Abou Jaoudeh
      • 09:30-09:50 Evaluation Of The Infertile Male.Abdulaziz Baazeem
      • 09:50-10:10 Medical Therapy for Infertile Males.Amr El-Meliegy
      • 10:10-10:30 Varicocele: Ongoing Debates.Shedeed Ashoor
      • 11:00-11:20 Modern Genetic Tests and Male Infertility.Sherif Ghazi
      • 11:20-11:40 Management Of Ejaculatory Disorders.Dulaim Alhajery
      • 11:40-12:00 Sperm banking for male cancer patients.Houssam Abdel Reda
      • 12:15-12:30 Deleterious effects of sperm DNA damage on male fertility.Parviz Gharagozloo
      • 12:30-12:45 Preclinical support for antioxidants in male infertility.Parviz Gharagozloo
      • 14:00-14:15 Predictive factors of pregnancy success with TESA.Rowaida Al Hamad
      • 14:15-14:30 Vitamin E and berberine counteract the adverse effects of ROS on sperm and seminal parameters.Nihal Adel
      Speakers